Holen Sie sich die Stockscreener-App
1.63
5.23%
-0.09
Schlusskurs vom Vortag:
$1.72
Offen:
$1.635
24-Stunden-Volumen:
46,217
Relative Volume:
0.03
Marktkapitalisierung:
$2.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.59M
KGV:
-0.00119
EPS:
-1373
Netto-Cashflow:
$-9.25M
1W Leistung:
+1.87%
1M Leistung:
+2.52%
6M Leistung:
-66.53%
1J Leistung:
-95.38%
1-Tages-Spanne:
$1.59
$1.69
1-Wochen-Bereich:
$1.52
$1.72
52-Wochen-Spanne:
$1.46
$37.50
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Firmenname
Bluejay Diagnostics Inc
Sektor
Branche
Telefon
(978) 631-0152
Adresse
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Vergleichen Sie BJDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.63 | 2.69M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
135.98 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.89 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.67 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.50 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.24 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Bluejay Diagnostics Inc Aktie (BJDX) Neueste Nachrichten
Bluejay Diagnostics (BJDX) Stock Skyrockets Over 44% on Nasdaq in Explosive Short-Term Rally - Daily Chhattisgarh News
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Initiates SYMON-II Clinical Study - TipRanks
Bluejay Diagnostics advances sepsis test, plans FDA filing By Investing.com - Investing.com South Africa
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Updat - GuruFocus
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Update | BJDX Stock News - GuruFocus
Bluejay Diagnostics advances sepsis test, plans FDA filing - Investing.com Australia
Bluejay Diagnostics Provides Mid-Year Business And Corporate Update - MarketScreener
Bluejay Diagnostics Slashes Workforce to Just 5 Employees as Cash Burns, Despite Promising Sepsis Trial Data - Stock Titan
Bluejay Diagnostics (NASDAQ:BJDX) Stock Price Up 1.2% – Here’s Why - Defense World
Bluejay Diagnostics announces CTO departure By Investing.com - Investing.com South Africa
Bluejay Diagnostics Announces CTO Departure Effective May 30 - TipRanks
Bluejay Diagnostics announces CTO departure - Investing.com Australia
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Bluejay Diagnostics, Inc. SEC 10-Q Report - TradingView
Bluejay Diagnostics Inc (BJDX) Stock: A Comprehensive 52-Week Review - investchronicle.com
Bluejay Diagnostics Inc (BJDX)’s stock price range in the last year - uspostnews.com
BJDX stock touches 52-week low at $1.6 amid steep annual decline - Investing.com Canada
BJDX stock touches 52-week low at $1.6 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline - Investing.com India
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Breakthrough Sepsis Test Could Predict Patient Mortality Risk, New Study Reveals - Stock Titan
Small Cap Stocks To Watch NowApril 7th - MarketBeat
US Markets Rebound As Global Trade Tensions Persist - Finimize
United States shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com India
Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com UK
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BJDX stock touches 52-week low at $3.01 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $3.01 amid steep annual decline - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
Wall Street Attempts Recovery From Tariff-Driven Losses as US Equity Futures Rise Pre-Bell - TradingView
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jack Kellogg Called The Market Bottom - timothysykes.com
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price - marketscreener.com
Bluejay Diagnostics Sinks Premarket Following Investor Agreement to Exercise Warrants at 'Reduced' Price - marketscreener.com
Bluejay Diagnostics enters into agreement with institutional investors - Medical Buyer
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - NewsBreak: Local News & Alerts
Bluejay Diagnostics (BJDX) Secures $3.7M Through Warrant Exercis - GuruFocus
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - The Manila Times
Bluejay Diagnostics Announces Entry Into Warrant Inducement Transaction For Approximately $3.7 Million In Gross Proceeds - marketscreener.com
Bluejay Diagnostics Raises Fresh $3.7M Capital: New Warrant Deal Strengthens Balance Sheet - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Vermilion Energy Inc. Confirms First Quarter 2025 Release Date and Filing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
'Magnificent 7' stocks continue getting hammered as Trump tariffs drag markets lower - Yahoo Finance
Finanzdaten der Bluejay Diagnostics Inc-Aktie (BJDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.51%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):